Fasting News and Research

RSS

Angiotensin 1-7 hormone offers hope for metabolic syndrome

Angiotensin 1-7, a hormone in the body that has cardiovascular benefits, improves the metabolic syndrome in rats, according to a new study. The results were presented at The Endocrine Society's 91st Annual Meeting in Washington, D.C.

10 Jun 2009

Do omega-3 fatty acids prevent depression in coronary heart disease?

Depression is an established risk factor for the development of coronary heart disease (CHD) in healthy patients and for adverse cardiovascular outcomes in patients with existing CHD. Dietary factors resulting in lower levels of omega-3 fatty acids not only increase CHD risk, but may also be involved in the pathophysiology of depression.

9 Jun 2009

Insomnia and sleep duration linked to diabetes

Individuals with insomnia and objective short sleep duration are at increased risk for developing diabetes, according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

9 Jun 2009

America’s epidemic of children with type 2 diabetes

With the number of children suffering from type 2 diabetes growing at an alarming rate, physicians gathered Saturday to discuss strategies for prevention and treatment of the disease among children and adolescents at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.

18 May 2009

Old diabetes drug Metformin teaches experts new tricks

Research from the Johns Hopkins Children's Center reveals that the drug most commonly used in type 2 diabetics who don't need insulin works on a much more basic level than once thought, treating persistently elevated blood sugar - the hallmark of type 2 diabetes - by regulating the genes that control its production.

15 May 2009

Is metabolic character different between men and women with gallstone disease?

There are a cluster of metabolic syndrome, that include obesity, high level of fasting plasma glucose, hypertriglyceridemia and hypertension, which is closely associated with the increased morbidity and mortality caused by several of the most common diseases including diabetes, hypertension, cardiovascular diseases, cancer and gallstone disease.

20 Apr 2009

Oral contraceptives impair muscle mass gains in young women

Many active young women use oral contraceptives (OC) yet its effect on their body composition and exercise performance has not been thoroughly studied.

20 Apr 2009

Seroquel XR supplemental NDA recommended for approval

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

9 Apr 2009

Teen girls catching up to boys in prevalence of metabolic syndrome

There appears to be an increased awareness of the need to get our nation's youth moving and eating well-schools are taking a critical look at the meal options provided to students, and with the emergence of interactive exercise video games, game-loving teens don't necessarily equal couch potatoes.

6 Apr 2009

Scientists detect molecular obesity link to insulin resistance, type II diabetes

A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.

2 Apr 2009

'Pre-diabetics' face heightened risk of heart disease

The study, published in the Journal of Clinical Endocrinology & Metabolism , was led by Jill P. Crandall, M.D., associate professor of clinical medicine and director of the Diabetes Clinical Trials Unit at Einstein.

2 Apr 2009

Drugs that act on 'fasting signal' may curb insulin resistance in obese

A report in the March issue of Cell Metabolism , a Cell Press publication, has found that a signal known to play a role during fasting also switches on early in the fat tissue of obese mice as they progress toward type 2 diabetes.

2 Apr 2009

Study looks at vitamin supplements for celiac disease

Coeliac disease is a typical example of a malabsorption syndrome conferring increased risk for various deficiency states, including folate and vitamin B12.

2 Apr 2009

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

29 Mar 2009

FDA approves Symbyax for treatment-resistant depression

The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company has announced.

23 Mar 2009

Nationwide alert on tainted weight loss products

The U.S. Food and Drug Administration is expanding, for the second time, its nationwide alert to consumers about tainted weight loss products containing

22 Mar 2009

Treatment of European coronary patients fails to meet standards of international guidelines

Large proportions of European coronary patients are failing to achieve lifestyle, risk factor and therapeutic targets for the prevention of further disease, according to results of the third EUROASPIRE survey.

12 Mar 2009

People who sleep less than six hours nightly risk developing diabetes

To the many problems associated with lack of sleep -- moodiness, memory problems, difficulty concentrating -- add the risk of developing diabetes.

12 Mar 2009

Low levels of vitamin D linked to several risk factors in teenagers

Low levels of vitamin D were associated with an increased risk of high blood pressure, high blood sugar and metabolic syndrome in teenagers, researchers reported at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.

11 Mar 2009

Molecular switch linked to obesity, insulin resistance, type II diabetes

A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.

3 Mar 2009